These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8195464)

  • 1. A comparison of venlafaxine, trazodone, and placebo in major depression.
    Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
    J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled trial of venlafaxine for the treatment of major depression.
    Schweizer E; Weise C; Clary C; Fox I; Rickels K
    J Clin Psychopharmacol; 1991 Aug; 11(4):233-6. PubMed ID: 1918421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine in depressed outpatients.
    Khan A; Fabre LF; Rudolph R
    Psychopharmacol Bull; 1991; 27(2):141-4. PubMed ID: 1924660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G; Wetzel H; Schlösser R; Benkert O
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice.
    Trick L; Stanley N; Rigney U; Hindmarch I
    J Psychopharmacol; 2004 Jun; 18(2):205-14. PubMed ID: 15260909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
    Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
    Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
    Shrivastava RK; Cohn C; Crowder J; Davidson J; Dunner D; Feighner J; Kiev A; Patrick R
    J Clin Psychopharmacol; 1994 Oct; 14(5):322-9. PubMed ID: 7806687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
    Mendels J; Johnston R; Mattes J; Riesenberg R
    Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy for depression with trazodone.
    Fabre LF; Feighner JP
    J Clin Psychiatry; 1983 Jan; 44(1):17-21. PubMed ID: 6337131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone in the treatment of neurotic depression.
    Goldberg HL; Finnerty RJ
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):430-4. PubMed ID: 7440519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bupropion and trazodone for the treatment of major depression.
    Weisler RH; Johnston JA; Lineberry CG; Samara B; Branconnier RJ; Billow AA
    J Clin Psychopharmacol; 1994 Jun; 14(3):170-9. PubMed ID: 8027413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.